Literature DB >> 12590711

Hematopoietic reconstitution of irradiated, stem cell-injected mice: early dynamics of restoration of the cell lineages of the spleen and bone marrow.

Sandra C Miller1.   

Abstract

Hematopoietic stem cells, numbering approximately 1/100,000 cells in mammalian bone marrow, are capable of complete hematopoietic and immune reconstitution upon injection into a myeloablated host. The present study aimed to analyze the earliest events in reconstitution of lethally irradiated, host murine bone marrow and spleen, after injecting purified Thy 1(lo)Lin(-)Sca-1(+) stem cells. Thy-1(lo)Lin(-)Sca-1(+) cells were isolated by fluorescence-activated cell sorting (FACS) from the bone marrow of 4-week-old C57BL(Thy1.1, Ly5.1) mice and injected into preirradiated, syngeneic hosts. These stem cells were also injected into congenic hosts, i.e., C57BL(Thy1.2, Ly5.2), and confirmed the donor origin of hematopoietic cells in the reconstituted host mice. Hematologically stained smears of the spleen and bone marrow of stem cell-injected recipients were prepared at 11, 14, 17, 21, 24, and 28 days after stem cell injection, and nucleated erythroid cells, mature granulocytes, and their myeloid precursors, monocytes, and large and small lymphocytes were recorded as a proportion of all nucleated cells in each organ at each time interval. The results indicated that in the earliest post stem cell injection intervals, both organs were predominantly erythroid and myeloid. Only at the later intervals did both organs show high proportions of large lymphoid cells and their progeny, small lymphocytes. Thus, early (<1 month) dynamics of hematopoietic reconstitution after transplantation of purified hematopoietic stem cells, is cell lineage specific.

Entities:  

Mesh:

Year:  2002        PMID: 12590711     DOI: 10.1089/152581602321080628

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN: 1525-8165


  2 in total

1.  Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells.

Authors:  Inez Johanna; Trudy Straetemans; Sabine Heijhuurs; Tineke Aarts-Riemens; Håkan Norell; Laura Bongiovanni; Alain de Bruin; Zsolt Sebestyen; Jürgen Kuball
Journal:  J Immunother Cancer       Date:  2019-03-12       Impact factor: 13.751

2.  Multimodal Tracking of Hematopoietic Stem Cells from Young and Old Mice Labeled with Magnetic-Fluorescent Nanoparticles and Their Grafting by Bioluminescence in a Bone Marrow Transplant Model.

Authors:  Fernando A Oliveira; Mariana P Nucci; Javier B Mamani; Arielly H Alves; Gabriel N A Rego; Andrea T Kondo; Nelson Hamerschlak; Mara S Junqueira; Lucas E B de Souza; Lionel F Gamarra
Journal:  Biomedicines       Date:  2021-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.